Literature DB >> 25188548

Identification of a nonsynonymous polymorphism in the SVEP1 gene associated with altered clinical outcomes in septic shock.

Taka-aki Nakada1, James A Russell, John H Boyd, Simone A Thair, Keith R Walley.   

Abstract

OBJECTIVES: Mortality from septic shock is highly heritable. The identification of causal genetic factors is insufficient. To discover key contributors, we first identified nonsynonymous single-nucleotide polymorphisms in conserved genomic regions that are predicted to have significant effects on protein function. We then test the hypothesis that these nonsynonymous single-nucleotide polymorphisms across the genome alter clinical outcome of septic shock.
DESIGN: Genetic-association study plus in vitro experiment using primary cells plus in silico analysis using genomic DNA and protein database.
SETTING: Twenty-seven ICUs at academic teaching centers in Canada, Australia, and the United States. PATIENTS: Patients with septic shock of European ancestry (n = 520).
INTERVENTIONS: Patients with septic shock were genotyped for 843 nonsynonymous single-nucleotide polymorphisms in conserved regions of the genome and are predicted to have damaging effects from the protein sequence.
MEASUREMENTS AND MAIN RESULTS: The primary outcome variable was 28-day mortality. Secondary outcome variables were organ dysfunction. Productions of adhesion molecules including interleukin-8, growth-regulated oncogene-α, monocyte chemoattractant protein-1, and monocyte chemoattractant protein-3 were measured in human umbilical vein endothelial cells after SVEP1 gene silencing by RNA interference. Patients with septic shock having the SVEP1 C allele of nonsynonymous single-nucleotide polymorphism, SVEP1 c.2080A>C (p. Gln581His, rs10817033), had a significant increase in the hazard of death over the 28 days (hazard ratio, 1.72; 95% CI, 1.31-2.26; p = 9.7 × 10-5) and increased organ dysfunction and needed more organ support (p < 0.05). Silencing SVEP1 significantly increased interleukin-8, growth-regulated oncogene-α, monocyte chemoattractant protein-1, monocyte chemoattractant protein-3 production in human umbilical vein endothelial cells under lipopolysaccharide stimulation (p < 0.01).
CONCLUSIONS: C allele of SVEP1 c.2080A>C (p. Gln581His) single-nucleotide polymorphism, a non-synonymous single-nucleotide polymorphism in conserved regions and predicted to have damaging effects on protein structure, was associated with increased 28-day mortality and organ dysfunction of septic shock. SVEP1 appears to regulate molecules of the leukocyte adhesion pathway.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25188548     DOI: 10.1097/CCM.0000000000000604

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  11 in total

1.  SVEP1 plays a crucial role in epidermal differentiation.

Authors:  Liat Samuelov; Qiaoli Li; Ron Bochner; Nicole A Najor; Lauren Albrecht; Natalia Malchin; Tomer Goldsmith; Meital Grafi-Cohen; Dan Vodo; Gilad Fainberg; Benjamin Meilik; Ilan Goldberg; Emily Warshauer; Tova Rogers; Sarah Edie; Akemi Ishida-Yamamoto; Lisa Burzenski; Noam Erez; Steve A Murray; Alan D Irvine; Lenny Shultz; Kathleen J Green; Jouni Uitto; Eli Sprecher; Ofer Sarig
Journal:  Exp Dermatol       Date:  2017-02-20       Impact factor: 3.960

2.  Finding a needle in the haystack: leveraging bioinformatics to identify a functional genetic risk factor for sepsis death.

Authors:  Nuala J Meyer
Journal:  Crit Care Med       Date:  2015-01       Impact factor: 7.598

3.  Proteomics and Risk of Atrial Fibrillation in Older Adults (From the Atherosclerosis Risk in Communities [ARIC] Study).

Authors:  Faye L Norby; Weihong Tang; James S Pankow; Pamela L Lutsey; Alvaro Alonso; Brian Steffan; Lin Y Chen; Michael Zhang; Nathan D Shippee; Christie M Ballantyne; Eric Boerwinkle; Josef Coresh; Aaron R Folsom
Journal:  Am J Cardiol       Date:  2021-12-15       Impact factor: 3.133

Review 4.  Integrating "big data" into surgical practice.

Authors:  Brittany Mathias; Gigi Lipori; Lyle L Moldawer; Philip A Efron
Journal:  Surgery       Date:  2015-10-23       Impact factor: 3.982

Review 5.  Epidemiologic trends of sepsis in western countries.

Authors:  Alejandro Suarez De La Rica; Fernando Gilsanz; Emilio Maseda
Journal:  Ann Transl Med       Date:  2016-09

6.  Genetic Polymorphisms and Cytokine Profile of Different Ethnicities inSeptic Shock Patients and their Association with Mortality.

Authors:  Shahla Siddiqui; Resham Lal Gurung; Sylvia Liu; Edwin Chuen Ping Seet; Su Chi Lim
Journal:  Indian J Crit Care Med       Date:  2019-03

7.  Functional investigation of the coronary artery disease gene SVEP1.

Authors:  Michael J Winkler; Philipp Müller; Amin M Sharifi; Jana Wobst; Hanna Winter; Michal Mokry; Lijiang Ma; Sander W van der Laan; Shichao Pang; Benedikt Miritsch; Julia Hinterdobler; Julia Werner; Barbara Stiller; Ulrich Güldener; Tom R Webb; Folkert W Asselbergs; Johan L M Björkegren; Lars Maegdefessel; Heribert Schunkert; Hendrik B Sager; Thorsten Kessler
Journal:  Basic Res Cardiol       Date:  2020-11-13       Impact factor: 17.165

8.  Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease.

Authors:  Nathan O Stitziel; Kathleen E Stirrups; Nicholas G D Masca; Jeanette Erdmann; Paola G Ferrario; Inke R König; Peter E Weeke; Thomas R Webb; Paul L Auer; Ursula M Schick; Yingchang Lu; He Zhang; Marie-Pierre Dube; Anuj Goel; Martin Farrall; Gina M Peloso; Hong-Hee Won; Ron Do; Erik van Iperen; Stavroula Kanoni; Jochen Kruppa; Anubha Mahajan; Robert A Scott; Christina Willenberg; Peter S Braund; Julian C van Capelleveen; Alex S F Doney; Louise A Donnelly; Rosanna Asselta; Piera A Merlini; Stefano Duga; Nicola Marziliano; Josh C Denny; Christian M Shaffer; Nour Eddine El-Mokhtari; Andre Franke; Omri Gottesman; Stefanie Heilmann; Christian Hengstenberg; Per Hoffman; Oddgeir L Holmen; Kristian Hveem; Jan-Håkan Jansson; Karl-Heinz Jöckel; Thorsten Kessler; Jennifer Kriebel; Karl L Laugwitz; Eirini Marouli; Nicola Martinelli; Mark I McCarthy; Natalie R Van Zuydam; Christa Meisinger; Tõnu Esko; Evelin Mihailov; Stefan A Escher; Maris Alver; Susanne Moebus; Andrew D Morris; Martina Müller-Nurasyid; Majid Nikpay; Oliviero Olivieri; Louis-Philippe Lemieux Perreault; Alaa AlQarawi; Neil R Robertson; Karen O Akinsanya; Dermot F Reilly; Thomas F Vogt; Wu Yin; Folkert W Asselbergs; Charles Kooperberg; Rebecca D Jackson; Eli Stahl; Konstantin Strauch; Tibor V Varga; Melanie Waldenberger; Lingyao Zeng; Aldi T Kraja; Chunyu Liu; George B Ehret; Christopher Newton-Cheh; Daniel I Chasman; Rajiv Chowdhury; Marco Ferrario; Ian Ford; J Wouter Jukema; Frank Kee; Kari Kuulasmaa; Børge G Nordestgaard; Markus Perola; Danish Saleheen; Naveed Sattar; Praveen Surendran; David Tregouet; Robin Young; Joanna M M Howson; Adam S Butterworth; John Danesh; Diego Ardissino; Erwin P Bottinger; Raimund Erbel; Paul W Franks; Domenico Girelli; Alistair S Hall; G Kees Hovingh; Adnan Kastrati; Wolfgang Lieb; Thomas Meitinger; William E Kraus; Svati H Shah; Ruth McPherson; Marju Orho-Melander; Olle Melander; Andres Metspalu; Colin N A Palmer; Annette Peters; Daniel Rader; Muredach P Reilly; Ruth J F Loos; Alex P Reiner; Dan M Roden; Jean-Claude Tardif; John R Thompson; Nicholas J Wareham; Hugh Watkins; Cristen J Willer; Sekkar Kathiresan; Panos Deloukas; Nilesh J Samani; Heribert Schunkert
Journal:  N Engl J Med       Date:  2016-03-02       Impact factor: 91.245

Review 9.  The impact of genome-wide association studies on the pathophysiology and therapy of cardiovascular disease.

Authors:  Thorsten Kessler; Baiba Vilne; Heribert Schunkert
Journal:  EMBO Mol Med       Date:  2016-07-01       Impact factor: 12.137

10.  The novel miR-1269b-regulated protein SVEP1 induces hepatocellular carcinoma proliferation and metastasis likely through the PI3K/Akt pathway.

Authors:  Lu Chen; Dongming Liu; Xianfu Yi; Lisha Qi; Xiangdong Tian; Bo Sun; Qiuping Dong; Zhiqiang Han; Qiang Li; Tianqiang Song; Mingxi Guo; Wei Zhang; Hua Guo; Ti Zhang
Journal:  Cell Death Dis       Date:  2020-05-05       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.